Company: PTPI
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001104659-25-025104
Chunk: 75

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 75
---
 BOARD WILL BE VOTED IN FAVOR THEREOF
UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THE PROXY.

45

PROPOSAL NO. 5 - THE ADJOURNMENT PROPOSAL</div>

Background of and Rationale for the Adjournment Proposal

The Board believes that
if the number of shares of the Company’s Common Stock and Series A Preferred Stock outstanding and entitled to vote at the
Special Meeting and voting in favor of any one or more of the proposals presented at the Special Meeting is insufficient to approve such
proposals, it is in the best interests of the stockholders to enable the Board to continue to seek to obtain a sufficient number of additional
votes to approve such proposals.

In the Adjournment Proposal,
we are asking stockholders to authorize the holder of any proxy solicited by the Board to vote in favor of adjourning or postponing the
Special Meeting or any adjournment or postponement thereof. If our stockholders approve this proposal, we could adjourn or postpone the
Special Meeting, and any adjourned session of the Special Meeting, to use the additional time to solicit additional proxies in favor
of any one or more of the proposals presented at the Special Meeting.

Additionally, approval of
the Adjournment Proposal could mean that, in the event we receive proxies indicating that we will not obtain approval for one or more
of the proposals presented at the Special Meeting, we could adjourn or postpone the Special Meeting without a vote on such proposals
and use the additional time to solicit the holders of those shares to change their vote in favor of such proposals.

Required Vote

The affirmative vote of the holders of a majority of the stock having
voting power present by virtual attendance or represented by proxy at the Special Meeting and entitled to vote on the Adjournment Proposal
is required to approve the Adjournment Proposal. “ABSTAIN” votes will have the same effect as votes cast “AGAINST”
the Adjournment Proposal. Because the Adjournment Proposal is considered a routine matter, your bank, broker, trustee or other nominee,
as the case may be, may vote your shares without your instruction with respect to the Adjournment Proposal unless you instruct them otherwise.
Failure by your bank, broker, trustee or other nominee to exercise this discretionary authority will have no effect on the results for
the Adjournment Proposal.

<div align='center'>THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE “FOR